Curing the highcost-syndrome

The Health Ministry's announcement last week that it is working on a proposal to cap the prices of more than 1,000 essential medicines is welcome, though the move is long overdue. For a long time, the question of drugs has been a bone of contention between Malaysian health activists and cons...

Full description

Bibliographic Details
Main Author: Abd Razak, Dzulkifli
Format: Article
Language:English
Published: 2006
Subjects:
Online Access:http://eprints.usm.my/33411/
http://eprints.usm.my/33411/1/DZUL323.pdf
_version_ 1848877065417261056
author Abd Razak, Dzulkifli
author_facet Abd Razak, Dzulkifli
author_sort Abd Razak, Dzulkifli
building USM Institutional Repository
collection Online Access
description The Health Ministry's announcement last week that it is working on a proposal to cap the prices of more than 1,000 essential medicines is welcome, though the move is long overdue. For a long time, the question of drugs has been a bone of contention between Malaysian health activists and consumers. The last time Malaysia discussed this issue was almost a decade ago but it was of little avail. Maybe this time it will be different. A survey recently (NST, May 9) showed that many Malaysians pay exorbitant prices for their medicines. In fact, drug prices in Malaysia are far above the international reference pricing, a guide on how much medicine should cost. The ministry's list of essential medicines will include antibiotics, aspirin and other painkillers, as well as medicines for high blood pressure and depression.
first_indexed 2025-11-15T17:09:31Z
format Article
id usm-33411
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T17:09:31Z
publishDate 2006
recordtype eprints
repository_type Digital Repository
spelling usm-334112017-04-19T09:02:49Z http://eprints.usm.my/33411/ Curing the highcost-syndrome Abd Razak, Dzulkifli R Medicine (General) The Health Ministry's announcement last week that it is working on a proposal to cap the prices of more than 1,000 essential medicines is welcome, though the move is long overdue. For a long time, the question of drugs has been a bone of contention between Malaysian health activists and consumers. The last time Malaysia discussed this issue was almost a decade ago but it was of little avail. Maybe this time it will be different. A survey recently (NST, May 9) showed that many Malaysians pay exorbitant prices for their medicines. In fact, drug prices in Malaysia are far above the international reference pricing, a guide on how much medicine should cost. The ministry's list of essential medicines will include antibiotics, aspirin and other painkillers, as well as medicines for high blood pressure and depression. 2006-07-09 Article PeerReviewed application/pdf en http://eprints.usm.my/33411/1/DZUL323.pdf Abd Razak, Dzulkifli (2006) Curing the highcost-syndrome. New Sunday Times.
spellingShingle R Medicine (General)
Abd Razak, Dzulkifli
Curing the highcost-syndrome
title Curing the highcost-syndrome
title_full Curing the highcost-syndrome
title_fullStr Curing the highcost-syndrome
title_full_unstemmed Curing the highcost-syndrome
title_short Curing the highcost-syndrome
title_sort curing the highcost-syndrome
topic R Medicine (General)
url http://eprints.usm.my/33411/
http://eprints.usm.my/33411/1/DZUL323.pdf